ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007

Dietary Interventions Reduce Breast Cancer Risk In Trials

May 27, 2005

In Brief: James Carr Replaces Murphy As Interim Director of Organ Systems Coordinating Center In N.Y.

August 16, 1985

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013